(Q33384219)

26 July 2017

title

A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia (English)

1 reference

chronic lymphocytic leukemia

26 July 2017

0 references

1 reference

1 reference

1 reference

1 reference

Matthew Kaufman

1

1 reference

26 July 2017

Sewanti A Limaye

2

1 reference

26 July 2017

Nancy Driscoll

3

1 reference

26 July 2017

Christina Johnson

4

1 reference

26 July 2017

Angelica Caramanica

5

1 reference

26 July 2017

Yehuda Lebowicz

6

1 reference

26 July 2017

Dilip Patel

7

1 reference

26 July 2017

Nina Kohn

8

1 reference

26 July 2017

Kanti Rai

9

1 reference

26 July 2017

language of work or name

1 reference

1 June 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

50

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

892-899

1 reference

Autoimmune complications of chronic lymphocytic leukemia

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Splenectomy in advanced chronic lymphocytic leukemia: a single institution experience with 50 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Use of intravenous immunoglobulin in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Control of steroid-resistant autoimmune haemolytic anaemia by cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Successful treatment of steroid-resistant hemolysis in chronic lymphocytic leukemia with cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Advances in the use of monoclonal antibodies in the therapy of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Monoclonal antibodies in the treatment of autoimmune cytopenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

A review of Campath in autoimmune disease: biologic therapy in the gray zone between immunosuppression and immunoablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

The effect of treatment with Campath-1H in patients with autoimmune cytopenias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Rituximab for Immune Cytopenia in Adults: Idiopathic Thrombocytopenic Purpura, Autoimmune Hemolytic Anemia, and Evans Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902887563

10.1080/10428190902887563

21 January 2018

Identifiers

DOI

1 reference

release_iie4a6uf7zbxdjgvole6khbtsq

26 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iie4a6uf7zbxdjgvole6khbtsq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference